Published in Gut on April 05, 2012
Serrated neoplasia-role in colorectal carcinogenesis and clinical implications. Nat Rev Gastroenterol Hepatol (2015) 1.00
Serrated colon polyps as precursors to colorectal cancer. Clin Gastroenterol Hepatol (2012) 0.97
Risk factors for serrated polyps of the colorectum. Dig Dis Sci (2014) 0.96
Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol (2013) 0.91
Colorectal cancer diagnosis in 2012: A new focus for CRC prevention--more serration, less inflammation. Nat Rev Gastroenterol Hepatol (2013) 0.86
Serrated polyposis: colonic phenotype, extracolonic features, and familial risk in a large cohort. Dis Colon Rectum (2013) 0.86
Serrated polyps of right colon: guilty or innocent? Ann Gastroenterol (2013) 0.84
Extracolonic cancer risk in patients with serrated polyposis syndrome and their first-degree relatives. Fam Cancer (2013) 0.83
IGF2 differentially methylated region hypomethylation in relation to pathological and molecular features of serrated lesions. World J Gastroenterol (2014) 0.80
The molecular characteristics of colonic neoplasms in serrated polyposis: a systematic review and meta-analysis. J Pathol Clin Res (2016) 0.78
The relationship between EZH2 expression and microRNA-31 in colorectal cancer and the role in evolution of the serrated pathway. Oncotarget (2016) 0.78
How does the serrated polyp pathway alter CRC screening and surveillance? Dig Dis Sci (2015) 0.78
Clinicopathological Characteristics of Serrated Polyposis Syndrome in Korea: Single Center Experience. Gastroenterol Res Pract (2015) 0.77
Incidence and review of sessile serrated polyp reporting in a district general hospital in the UK. Virchows Arch (2013) 0.77
Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis. Clin Gastroenterol Hepatol (2015) 0.76
British Society of Gastroenterology position statement on serrated polyps in the colon and rectum. Gut (2017) 0.76
Sporadic duodenal adenoma and association with colorectal neoplasia: a case-control study. Dig Dis Sci (2014) 0.76
Who Needs Follow-Up after Endoscopic Resection of Colorectal Adenomas? Viszeralmedizin (2014) 0.75
Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol (2017) 0.75
Sessile Serrated Adenomas: How to Detect, Characterize and Resect. Gut Liver (2017) 0.75
Clinical characteristics of patients with serrated polyposis syndrome in Korea: comparison with Western patients. Intest Res (2017) 0.75
Serrated Polyps of Colon and Rectum: a Clinicopathologic Review. J Gastrointest Cancer (2017) 0.75
Microsatellite instability in colorectal cancer. Gastroenterology (2010) 7.39
Role of the serrated pathway in colorectal cancer pathogenesis. Gastroenterology (2010) 4.25
Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol (1990) 3.89
Increased colorectal cancer risk during follow-up in patients with hyperplastic polyposis syndrome: a multicentre cohort study. Gut (2009) 3.34
The chromosomal instability pathway in colon cancer. Gastroenterology (2010) 2.59
Hyperplastic polyps and sessile serrated adenomas as a phenotypic expression of MYH-associated polyposis. Gastroenterology (2008) 2.41
Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut (2000) 1.95
Proximal and large hyperplastic and nondysplastic serrated polyps detected by colonoscopy are associated with neoplasia. Gastroenterology (2010) 1.95
Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut (2010) 1.94
Epidemiology of colorectal cancer. Br Med Bull (2002) 1.87
Phenotypic and molecular characteristics of hyperplastic polyposis. Gastroenterology (2000) 1.86
Serrated route to colorectal cancer: back street or super highway? J Pathol (2001) 1.73
Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology (2006) 1.66
Sporadic and syndromic hyperplastic polyps and serrated adenomas of the colon: classification, molecular genetics, natural history, and clinical management. Gastroenterol Clin North Am (2008) 1.65
Familial giant hyperplastic polyposis predisposing to colorectal cancer: a new hereditary bowel cancer syndrome. J Pathol (1996) 1.38
Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum (2011) 1.36
Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis (2010) 1.27
A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol (2011) 1.16
Management of Portuguese patients with hyperplastic polyposis and screening of at-risk first-degree relatives: a contribution for future guidelines based on a clinical study. Am J Gastroenterol (2004) 1.15
Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol (2004) 1.14
Hyperplastic polyposis: semantics, biology, and endoscopy. Gut (2010) 1.08
Serrated adenoma and colorectal cancer. J Pathol (1999) 1.04
Risk factors: Hyperplastic polyposis syndrome and risk of colorectal cancer. Nat Rev Gastroenterol Hepatol (2010) 0.99
Hyperplastic polyposis syndrome and the risk of colorectal cancer. Gut (2011) 0.89
Sessile serrated adenoma: a brief history and current status. Crit Rev Oncog (2006) 0.87
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin (2008) 12.90
The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature (2010) 12.43
Circulating mutant DNA to assess tumor dynamics. Nat Med (2007) 10.33
Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2012) 8.51
Loss of IGF2 imprinting: a potential marker of colorectal cancer risk. Science (2003) 6.85
Haploinsufficiency of telomerase reverse transcriptase leads to anticipation in autosomal dominant dyskeratosis congenita. Proc Natl Acad Sci U S A (2005) 4.64
Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA (2006) 4.34
Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol (2006) 4.22
Frequency and spectrum of cancers in the Peutz-Jeghers syndrome. Clin Cancer Res (2006) 3.81
Small changes in expression affect predisposition to tumorigenesis. Nat Genet (2001) 3.37
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proc Natl Acad Sci U S A (2004) 3.35
Clinically relevant changes in family history of cancer over time. JAMA (2011) 3.18
Primary chemoprevention of familial adenomatous polyposis with sulindac. N Engl J Med (2002) 3.16
Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach. Clin Gastroenterol Hepatol (2004) 3.10
Midline carcinoma of children and young adults with NUT rearrangement. J Clin Oncol (2004) 2.92
A Trial of Calcium and Vitamin D for the Prevention of Colorectal Adenomas. N Engl J Med (2015) 2.88
A clinically relevant population of leukemic CD34(+)CD38(-) cells in acute myeloid leukemia. Blood (2012) 2.65
Aberrant crypt foci in the adenoma prevention with celecoxib trial. Cancer Prev Res (Phila) (2008) 2.47
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2010) 2.45
Inflammatory myofibroblastic tumors of the urinary tract: a clinicopathologic study of 46 cases, including a malignant example inflammatory fibrosarcoma and a subset associated with high-grade urothelial carcinoma. Am J Surg Pathol (2006) 2.34
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13
Loss of imprinting of insulin growth factor II gene: a potential heritable biomarker for colon neoplasia predisposition. Gastroenterology (2004) 2.06
Impact of genetic counseling and testing on colorectal cancer screening behavior. Genet Test (2002) 1.81
Clonal cytogenetic abnormalities and BCL2 rearrangement in interdigitating dendritic cell sarcoma. Leuk Lymphoma (2006) 1.68
High incidence of microsatellite instability in colorectal cancer from African Americans. Clin Cancer Res (2003) 1.68
Risk of colorectal cancer in juvenile polyposis. Gut (2007) 1.64
Relative frequency and morphology of cancers in STK11 mutation carriers. Gastroenterology (2004) 1.62
Combination treatment with curcumin and quercetin of adenomas in familial adenomatous polyposis. Clin Gastroenterol Hepatol (2006) 1.57
Genetic/familial high-risk assessment: breast and ovarian, version 1.2014. J Natl Compr Canc Netw (2014) 1.48
Importance of immunoglobulin heavy chain variable region mutational status in del(13q) chronic lymphocytic leukemia. Leuk Lymphoma (2011) 1.45
Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study. Gastroenterology (2002) 1.45
Effects of imatinib and interferon on primitive chronic myeloid leukaemia progenitors. Br J Haematol (2005) 1.41
Perceptions of genetic discrimination among at-risk relatives of colorectal cancer patients. Genet Med (2004) 1.39
Utilization of a TFE3 break-apart FISH assay in a renal tumor consultation service. Am J Surg Pathol (2013) 1.35
Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study. Clin Gastroenterol Hepatol (2008) 1.32
Clinicopathological features and microsatellite instability (MSI) in colorectal cancers from African Americans. Int J Cancer (2005) 1.26
Incidence and mortality rates for colorectal cancer in Puerto Rico and among Hispanics, non-Hispanic whites, and non-Hispanic blacks in the United States, 1998-2002. Cancer (2009) 1.26
Juvenile polyposis syndrome. World J Gastroenterol (2011) 1.26
Familial adenomatous polyposis. Gastrointest Endosc (2003) 1.22
Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism. Clin Cancer Res (2005) 1.21
Gastrointestinal polyposis syndromes. Curr Mol Med (2007) 1.18
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res (2008) 1.17
Chemoprevention in familial adenomatous polyposis. Best Pract Res Clin Gastroenterol (2011) 1.17
Genetic testing for hereditary colorectal cancer in children: long-term psychological effects. Am J Med Genet A (2003) 1.15
Characterization of chronic myeloid leukemia stem cells. Am J Hematol (2011) 1.15
Genetic/Familial High-Risk Assessment: Colorectal Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw (2016) 1.12
Chemoprevention strategies using NSAIDs and COX-2 inhibitors. Cancer Biol Ther (2003) 1.11
Rapid development of colorectal neoplasia in patients with Lynch syndrome. Clin Gastroenterol Hepatol (2010) 1.11
RANBP2 and CLTC are involved in ALK rearrangements in inflammatory myofibroblastic tumors. Cancer Genet Cytogenet (2007) 1.10
Hypoxia-inducible factor-1 target genes as indicators of tumor vessel response to vascular endothelial growth factor inhibition. Cancer Res (2008) 1.09
Upper GI tract lesions in familial adenomatous polyposis (FAP): enrichment of pyloric gland adenomas and other gastric and duodenal neoplasms. Am J Surg Pathol (2014) 1.09
Molecular confirmation of t(6;11)(p21;q12) renal cell carcinoma in archival paraffin-embedded material using a break-apart TFEB FISH assay expands its clinicopathologic spectrum. Am J Surg Pathol (2012) 1.08
SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome. Clin Cancer Res (2010) 1.08
GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. PLoS One (2011) 1.05
Cytogenetic study of malignant triton tumor: a case report. Cancer Genet Cytogenet (2003) 1.04
Colorectal cancer screening. J Natl Compr Canc Netw (2013) 1.02
Prostanoids, ornithine decarboxylase, and polyamines in primary chemoprevention of familial adenomatous polyposis. Gastroenterology (2004) 1.01
Graft-versus-host reactions and the effectiveness of donor lymphocyte infusions. Biol Blood Marrow Transplant (2006) 0.99
High mobility group protein I(Y): a candidate architectural protein for chromosomal rearrangements in prostate cancer cells. Cancer Res (2002) 0.98
Ethnic and sex disparities in colorectal neoplasia among Hispanic patients undergoing screening colonoscopy. Clin Gastroenterol Hepatol (2012) 0.98
Sporadic fundic gland polyposis: a clinical, histological, and molecular analysis. Mod Pathol (2002) 0.97
Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw (2006) 0.97
Sulindac inhibits beta-catenin expression in normal-appearing colon of hereditary nonpolyposis colorectal cancer and familial adenomatous polyposis patients. Cancer Epidemiol Biomarkers Prev (2005) 0.97
Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc (2014) 0.94
Mismatch repair protein expression and colorectal cancer in Hispanics from Puerto Rico. Fam Cancer (2010) 0.94
Establishment and characterization of a new cell line, A99, from a primary small cell carcinoma of the pancreas. Pancreas (2011) 0.93
Lymph node harvest after proctectomy for invasive rectal adenocarcinoma following neoadjuvant therapy: does the same standard apply? Dis Colon Rectum (2009) 0.93
Detection of tumor DNA at the margins of colorectal cancer liver metastasis. Clin Cancer Res (2011) 0.93
Lymphoplasmacytic chronic cholecystitis and biliary tract disease in patients with lymphoplasmacytic sclerosing pancreatitis. Am J Surg Pathol (2003) 0.93
Beneficial effects of the bioflavonoids curcumin and quercetin on early function in cadaveric renal transplantation: a randomized placebo controlled trial. Transplantation (2005) 0.93
Chromosomal abnormalities of adenocarcinoma of the pancreas: identifying early and late changes. Cancer Genet Cytogenet (2007) 0.92
Familial pancreatic cancer: from genes to improved patient care. Expert Rev Gastroenterol Hepatol (2007) 0.92
Temporal stability and age-related prevalence of loss of imprinting of the insulin-like growth factor-2 gene. Epigenetics (2009) 0.91
Increased expression of cytoplasmic HuR in familial adenomatous polyposis. Cancer Biol Ther (2007) 0.91
Antibodies to saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm Bowel Dis (2007) 0.91
Cyclooxygenase 2 expression and molecular alterations in Peutz-Jeghers hamartomas and carcinomas. Clin Cancer Res (2003) 0.90
Multiple colorectal neoplasms in X-linked agammaglobulinemia. Clin Gastroenterol Hepatol (2007) 0.90
Diagnosis and management of hereditary colon cancer. Gastroenterol Clin North Am (2002) 0.90
Loss of imprinting and abnormal expression of the insulin-like growth factor 2 gene in gastric cancer. Mol Carcinog (2011) 0.89
Patient perspective on the value of genetic counselling for familial pancreas cancer. Hered Cancer Clin Pract (2005) 0.89
Active recruitment increased enrollment in a hereditary cancer registry. J Clin Epidemiol (2004) 0.89
Genomic changes in gliomas detected using single nucleotide polymorphism array in formalin-fixed, paraffin-embedded tissue: superior results compared with microsatellite analysis. J Mol Diagn (2011) 0.88